Meeting Coverage
Expert Perspectives
Journal Review
Podcasts & Audio
Click the cover below to access the NPPA November-December 2024 digital edition.
Lawrence Eichenfield, MD: Insights from the TRuE-AD3 Pediatric Atopic Dermatitis Trial
Tristan Hasbargen, PA-C: Setting Expectations for a Long-Term Approach to Repigmentation
David Rosmarin, MD: Efficacy of Ruxolitinib Cream in Progressive and Stable Vitiligo
Ted Lain, MD, MBA: Reviewing Results of the THRIVE-AA1 Trial in Severe Alopecia Areata
Leon Kircik, MD: Maximizing Bioavailability and Patient Outcomes With Oral Acne Therapy
Christopher Bunick, MD, PhD: Providing Rapid Itch Relief for Patients With Atopic Dermatitis
Letter to the Editor: March 2026
The Impact of Dupilumab on Psychological Wellbeing in Moderate-to-Severe Atopic Dermatitis Patients: A Phase IV Clinical Trial
Expanding the Topical Therapeutic Landscape for Atopic Dermatitis: A Systematic Review
A Multicenter Trial Evaluating the Safety and Efficacy of a Serum Containing Plant Adaptogens in Patients With Mild-to-Moderate, Persistent Centrofacial Erythema Associated With Rosacea
Pumping Up Dermatologic Drug Reformulation: A Review of How Proton Pump Inhibitors May Revolutionize Scleroderma Treatment
Mohs Surgeons’ Postoperative Care Practices for Secondary Intention Healing: A National Survey
Lichenoid Drug Eruption From Cetirizine Treated With Upadacitinib and Dupilumab
David Cotter, MD, PhD: Patient Presentation and Clinical Trial Data for Prurigo Nodularis
James Song, MD, FAAD: Assessing Systemic GPP Treatment With Targeted Therapy
